about
Effects of Bariatric Surgery on Mortality in Swedish Obese SubjectsRegulation of human aldoketoreductase 1C3 (AKR1C3) gene expression in the adipose tissueRelations of adipose tissue CIDEA gene expression to basal metabolic rate, energy restriction, and obesity: population-based and dietary intervention studies.Tenomodulin is highly expressed in adipose tissue, increased in obesity, and down-regulated during diet-induced weight loss.Regulation of the fibrosis and angiogenesis promoter SPARC/osteonectin in human adipose tissue by weight change, leptin, insulin, and glucoseRole of the gut in visceral fat inflammation and metabolic disorders.Effect of weight reduction on glycated haemoglobin in weight loss trials in patients with type 2 diabetes.Cell death-inducing DFF45-like effector C is reduced by caloric restriction and regulates adipocyte lipid metabolism.Differences in associations between HSD11B1 gene expression and metabolic parameters in subjects with and without impaired glucose homeostasis.Preliminary report: Zn-alpha2-glycoprotein genotype and serum levels are associated with serum lipids.Adipose tissue is not an important source for matrix metalloproteinase-9 in the circulation.Dissociation between adipose tissue expression and serum levels of adiponectin during and after diet-induced weight loss in obese subjects with and without the metabolic syndrome.The expression of NAD(P)H:quinone oxidoreductase 1 is high in human adipose tissue, reduced by weight loss, and correlates with adiposity, insulin sensitivity, and markers of liver dysfunction.Changes in human adipose tissue gene expression during diet-induced weight loss.Intestinal permeability is associated with visceral adiposity in healthy women.A microarray search for genes predominantly expressed in human omental adipocytes: adipose tissue as a major production site of serum amyloid A.Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trialBioequivalence of Saxagliptin/Metformin Extended-Release (XR) Fixed-Dose Combination Tablets and Single-Component Saxagliptin and Metformin XR Tablets in Healthy Adult Chinese SubjectsIdentification of Adipocyte Genes Regulated by Caloric IntakeCirculating matrix metalloproteinase 9 levels in relation to sampling methods, femoral and carotid atherosclerosisBeta-Cell Function, Self-rated Health, and Lifestyle Habits in 64-Year-Old Swedish Women with Metabolically Healthy Obesity PhenotypeThe human secretomeIndividual and stable autoantibody repertoires in healthy individualsResearch participants' preferences for receiving genetic risk information: a discrete choice experiment
P50
Q22250885-7F2E6FAE-4649-4CBB-A153-AC420069071FQ24315816-C55FE0F7-B308-4909-9F4F-5AB14548D0FBQ34693194-1573E52E-6A46-45CC-BE90-C58224E692E4Q34992294-A08CABFA-F537-43C6-A7F0-324D165B9E2BQ37267107-CC392EE8-69D8-4D98-ACFF-907DEBA7EF57Q37924590-FF83439C-0EFF-4741-BD56-09D31A2BFB78Q38729150-4F97456B-1355-4ECD-B175-ACEFBDB6730FQ42440258-244276AA-F5B5-41BF-BDA6-23F1B888E086Q43104432-2D8A3A1E-2A35-4F6E-857C-4452DBD9E331Q43195498-2127E5AC-4D34-40F5-8A3B-44BE78CF644EQ45941241-76DDB16D-D230-4FED-AF80-7EE0A9D3CBC6Q47280422-0B4D30A8-304A-4B6E-B360-01200C13F918Q47294241-9E89CE9A-09CB-4512-B698-2E907665AC57Q47578306-01532BA6-BFE9-4D1C-84D8-AF37337E4D9BQ51424599-17CCAA3F-1704-4BA8-99A8-9EDAB92D80B2Q54687423-7EF5BA67-6287-48D6-88B3-8B47666F327EQ58418687-87163D9D-BDD8-4D2F-A399-14F48CA5C77DQ59487668-CBAF17D1-3326-4741-9F93-5BB197858291Q59487670-8BA263CE-D17D-427A-B05F-60C2287B1AACQ59487672-C826C56A-8AED-4423-B882-0AF098E7D328Q90570742-F6473698-4F91-4B55-A887-DD11A4656C9CQ91473275-BE8683F8-072F-4155-8509-4ECF0C19CA21Q92139454-8429F9AD-7FE5-4EB1-A570-A457D93863EDQ93139007-F3FF7BD4-C529-41AB-A569-F62864885BE4
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Anders Gummesson
@ast
Anders Gummesson
@en
Anders Gummesson
@es
Anders Gummesson
@nl
type
label
Anders Gummesson
@ast
Anders Gummesson
@en
Anders Gummesson
@es
Anders Gummesson
@nl
prefLabel
Anders Gummesson
@ast
Anders Gummesson
@en
Anders Gummesson
@es
Anders Gummesson
@nl
P214
P906
P106
P21
P214
P31
P496
0000-0003-0024-960X
P569
1973-01-01T00:00:00Z
P735
P7859
viaf-86431786